1 not yet recruiting, 1 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Plasma Cell Leukemia (PCL): new trials by email Literature Review of Plasma Cell Leukemia (PCL) trials Research Report on Plasma Cell Leukemia (PCL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma IASO104 - Relapsed/Refractory Multiple Myeloma (RRMM), Plasma Cell Leukemia (PCL) | Early Phase 1 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 40 | 2026-02-15 | 2026-01-20 |
| Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research Metabolically Armed BCMA CAR-T cells. - Multiple Myeloma (MM), Plasma Cell Leukemia (PCL) | Early Phase 1 | Recruiting | Anhui Provincial Hospital | 36 | 2025-06-23 | 2025-07-25 |
Leukemia, Plasma Cell (2) · Multiple Myeloma (2) · Immunoglobulin Light-chain Amyloidosis (1)
Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Plasma Cell (2) · Paraproteinemias (2) · Vascular Diseases (2)
Anhui Provincial Hospital (1) · Institute of Hematology & Blood Diseases Hospital, China (1)
China (1)